From Root to Ritual
Why one botanical is never enough — and what the research says about combining them.
The perimenopausal hair loss conversation medicine keeps having wrong.
More than half of women report noticeable hair thinning by menopause. The most commonly offered treatment is a drug repurposed from blood pressure medicine that addresses one of five simultaneous drivers. A randomised trial just confirmed a botanical compound addresses four of those five. Here is what the perimenopausal hair loss conversation keeps getting wrong.
An oral drug just grew 30 extra hairs per square centimetre. Here is what that tells us about where hair loss actually lives.
Veradermics just published Phase 3 results for an oral hair loss pill — 30 to 33 additional hairs per cm² over six months, compared to seven in the placebo group. The most important thing about it isn’t the number. It’s that it works when swallowed. Which means the blood is the right delivery route. Which means the hair loss was always systemic.
What five minutes before the world begins can actually do.
This week we covered the science — microbiome, cortisol, energy metabolism, cellular aging, gut biology. Today is Sunday. We’re not adding another mechanism. We’re talking about what you actually do with all of it. In five minutes. Before the world begins.
The hair loss conversation just moved to your gut.
A Mendelian randomization study just established likely causal — not just correlational — relationships between specific gut bacteria and androgenetic alopecia. The hair loss conversation has moved from the scalp to the gut. And this week’s research has mapped five separate systems all pointing in the same direction.
Scientists just mapped exactly how the hair follicle ages. The picture changes what prevention means.
Scientists just analysed 57,181 individual cells from human scalp tissue and mapped exactly how the hair follicle ages — cell by cell, signal by signal. The picture changes what prevention means. The cascade starts long before the drain fills.
One million people just told science exactly what causes their hair loss. Here is what the data says.
Over one million people just told science exactly what causes their hair loss. The AI found three dominant predictors: hormones, stress, and systemic health history. Not genetics alone. And the population most affected is not who the pharmaceutical model was built for. Here is what the data actually says.
The hair loss drug that works by changing how follicles produce energy. And what that tells us about everything else.
A drug entering Phase 3 trials doesn’t target hormones or blood flow. It targets the energy metabolism of the hair follicle itself — and in doing so, it may have explained why scalp massage, rosemary, ginger, and antioxidants all work. The follicles weren’t dead. They were waiting for energy.
Researchers just measured stress inside the hair shaft. Aromatherapy changed it.
A clinical trial just measured cortisol inside the hair shaft — the biological record of months of chronic stress. Eight weeks of aromatherapy reduced it. Not just the feeling of stress. The actual hormonal measurement stored in the hair. Here is what that means for the follicles forming right now.
The plant that just outperformed two pharmaceutical hair loss drugs in a clinical trial.
A clinical trial just confirmed that a plant-derived formulation activates the same molecular pathways that regenerative medicine has identified as central to hair growth — IGF-1, FGF-7, Wnt/β-catenin. The plant is Centella asiatica. Traditional medicine has been prescribing it for hair health for three thousand years. The trial took 56 days to confirm what the observation already knew.
Your scalp has a microbiome. It has been trying to warn you.
A new study can now predict androgenetic alopecia before it becomes visible — by reading the bacteria and fungi living on your scalp. The microbiome was signalling the problem the whole time. Here is what it was saying, and what it means for how you care for your scalp today.
The trichologist's verdict on 2026 hair trends: what works, what doesn't, and what nobody is saying.
Every year, a new wave of hair growth trends arrives — some from dermatology clinics, some from pharmaceutical pipelines, many from social media. In 2026, the wave is larger than usual. AI scalp analytics, red light therapy, peptide serums, exosome injections, methylene blue, castor oil, biotin, scalp massagers, cold plunging, biohacking protocols. The category has never been more crowded, more confusing, or more in need of someone willing to say what actually works.
Penny James, a double board-certified trichologist, published exactly that this year. Her breakdown of 2026 hair trends — written from a clinical practice perspective, not a marketing one — is one of the most useful documents in the current hair health conversation. Not because it validates the newest and most expensive interventions. Because it keeps returning to the same inconvenient truth: the scalp is living tissue, and most of what the beauty industry sells treats it as though it isn't.
FREE Shipping on all US Orders